Financial Data and Key Metrics Changes - Net sales increased by 4.6% to $358.2 million, driven by $24.9 million of inorganic sales from the acquisition of UW Solutions [9][11] - Adjusted EBITDA margin decreased to 12.4%, primarily due to lower price and volume, unfavorable mix, and higher material, tariff, and health insurance costs [9][11] - Adjusted diluted EPS declined to $0.98, primarily driven by lower adjusted EBITDA and higher interest expense [9][11] Business Line Data and Key Metrics Changes - Performance Services net sales increased, driven by inorganic sales from UW Solutions and strong organic growth of 18.6% [10][11] - Architectural Services recorded net sales growth and a sequential backlog increase of over $100 million [4][10] - Glass segment net sales declined, with adjusted EBITDA margin moderating due to reduced volume and price from lower end-market demand [10][11] - Metals segment net sales declined slightly, reflecting a less favorable mix, partially offset by higher volume and price [10][11] Market Data and Key Metrics Changes - The competitive environment for glass has not improved, leading to lowered expectations for glass volume and price [5][12] - Higher aluminum costs are expected to pressure pricing and volume in the Metals segment [5][12] - Bid activity for glass business remains up versus last year, but price pressures are impacting volume [5][12] Company Strategy and Development Direction - The company is focused on acquisitions that fit strategic and financial objectives, aiming to add differentiated products and expand geographic reach [7][8] - Project Fortify II actions and tariff mitigation efforts are in place to enhance organizational agility [6][7] - The company aims to drive year-over-year net sales and adjusted EPS growth in the second half of the fiscal year, primarily through Performance Services [6][12] Management's Comments on Operating Environment and Future Outlook - Management expressed disappointment over changes impacting guidance but remains optimistic about year-over-year growth in the second half [5][6] - The company is navigating a challenging macroeconomic environment while building a stronger foundation for future growth [6][17] - Management highlighted the importance of maintaining premium product pricing to protect margins despite competitive pressures [34][35] Other Important Information - The One Big Beautiful Bill Act is expected to provide a cash tax benefit primarily impacting fiscal 2026 [12] - The company has a consolidated leverage ratio of 1.5 and no near-term debt maturities, providing flexibility for future opportunities [11] Q&A Session Summary Question: Can you expand on the organic growth in Performance Services? - The strongest growth was seen in UW Solutions, regaining distribution and leveraging cross-selling opportunities [22][23] Question: What is driving the growth in the flooring side of the business? - Demand for flooring products is driven by automation in distribution centers, with significant interest from a global e-commerce retailer [24][25] Question: What is the reason for the increase in services backlog? - The backlog growth was driven by projects in the Northeast and efforts to expand into new markets [26][27] Question: What are the expectations for glass margins in the next two quarters? - Management expects mid-teens EBITDA margins despite competitive pressures [32][33] Question: How much of the lowered guide for metals is due to cost pressure? - The pressure is mainly from higher aluminum costs, impacting pricing and volume [36][37] Question: What is the realistic downside for FY2026 if market conditions worsen? - Continued upward cost pressure on aluminum could impact the EPS guidance range of $3.60 to $3.90 [50][51] Question: How sensitive is the surfaces segment to a potential slowdown? - Any significant slowdown is more likely to impact Q1 rather than Q3, with visibility into retail demand remaining stable [52][53]

Financial Data and Key Metrics Changes - Order intake grew by 6%, building on a 9% increase from the previous year [6] - Comparable sales increased by 1%, with a margin expansion of 130 basis points to 12.4% [7][32] - Adjusted EBITA margin range increased to between 11.3% and 11.8% for 2025, reflecting a 50 basis points increase [7][39] - Free cash flow for the full year is expected to be between €200 million and €400 million [8][40] Business Line Data and Key Metrics Changes - Diagnosis and Treatment (D&T) comparable sales decreased by 1% due to a high comparison base, but EBITA margin improved by 130 basis points to 13.5% [26][27] - Connected Care saw a 1% decline in comparable sales, with an EBITA margin improvement of 160 basis points to 10.4% [28] - Personal Health experienced strong growth across most geographies, although EBITA margin declined by 170 basis points to 15.2% due to increased costs [30] Market Data and Key Metrics Changes - Strong double-digit growth in North America and growth geographies for order intake [8][10] - China showed subdued consumer sentiment, impacting Personal Health sales, but there are signs of recovery [18][23] - Overall growth was supported by growth geographies, offset by a decline in China [31] Company Strategy and Development Direction - The company is focused on accelerating profitable growth and unlocking the full potential of its segments [42] - Emphasis on innovation and productivity measures to drive gross margins and operational efficiency [7][34] - Plans to host a Capital Markets Day in February to outline the next phase of strategy [42] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the second half of the year, supported by order intake momentum and a robust order book [43] - The tariff landscape remains dynamic, with expected impacts on margins in the second half of the year [39][40] - Management remains cautious about the Chinese market but sees potential for recovery [23][64] Other Important Information - The company has made significant progress in quality management and supply chain reliability, achieving an all-time high service level of 86% [21][20] - The company has achieved €2.1 billion in savings since the start of its three-year plan in 2023 [33] Q&A Session Questions and Answers Question: Can you talk about the improvement in D&T margins? - Management noted a 130 basis points margin expansion driven by gross margin improvements from innovations and productivity measures [49][50] Question: Why have you only banked the tariff improvement and not the EBITA beat in the quarter? - Management indicated that they are happy with the outlook revision but need to accelerate margin expansion in the second half while absorbing tariff impacts [51][52] Question: Can you unpack the decline in Connected Care in the quarter? - The decline was primarily driven by a low single-digit drop in monitoring, but management sees strong demand and order intake growth [53][54] Question: How far along are you in the European market on the system side versus prior to the recall? - Management stated it is too early to provide specific market share numbers but is rebuilding momentum in the market [57] Question: Can you provide color on the growth in ultrasound revenue? - Management indicated slight declines in ultrasound growth but expects performance to strengthen in the second half due to new launches [100] Question: How much of the advertising spend in Personal Health was in price? - Management clarified that pricing in Personal Health is broadly flat, with advertising aimed at driving innovation rather than price reductions [90]

Financial Data and Key Metrics Changes - Net sales increased by 4.6% to $346.6 million, primarily driven by $22 million of inorganic sales from the acquisition of UW Solutions [12] - Adjusted EBITDA margin decreased to 9.9%, primarily due to a less favorable mix and higher aluminum costs [13] - Adjusted diluted EPS declined to $0.56, driven by lower adjusted EBITDA, higher interest expense, and a higher adjusted effective tax rate [13] Business Line Data and Key Metrics Changes - Metals segment net sales declined by 3.4%, with adjusted EBITDA margin decreasing to 7.3% due to a less favorable mix and higher aluminum costs [13] - Services segment achieved a 7.6% increase in net sales, marking its fifth consecutive quarter of growth, although adjusted EBITDA margin decreased to 5.7% due to higher tariff expenses [14] - Glass segment net sales declined, with adjusted EBITDA margin moderating from elevated levels due to reduced volume from lower end market demand [14] - Performance Surfaces segment saw increased net sales driven by inorganic contributions from UW Solutions, with adjusted EBITDA margin declining to 18.8% [14] Market Data and Key Metrics Changes - The revenue pipeline for Glass is improving, positioning the segment for growth beginning in Q3 and into Q4 [8] - Metals showed solid sequential improvement from Q4, with expectations for continued improvement in Q2 [8][41] Company Strategy and Development Direction - The company is focusing on operational improvements and tariff mitigation efforts, with aggressive actions under Project Fortify expected to drive annualized savings of $13 million to $15 million [7][10] - The company is actively pursuing M&A opportunities to diversify its business mix and enhance growth prospects [11][18] Management's Comments on Operating Environment and Future Outlook - Management raised the fiscal year outlook for net sales and adjusted diluted EPS, expecting a strong second half driven by Performance Surfaces and improved glass results [11][19] - Management acknowledged ongoing market challenges but emphasized a focus on controllable factors to improve outlook [10] Other Important Information - The company expects net sales for the fiscal year to be in the range of $1.4 billion to $1.44 billion, with adjusted diluted EPS between $3.8 and $4.2 [16] - The unfavorable EPS impact from tariffs is estimated to be $0.35 to $0.45, primarily affecting the first half of the fiscal year [16] Q&A Session Summary Question: Can you elaborate on the glass business and the revenue pipeline? - Management noted good visibility six months out and mentioned a pivot to smaller jobs to fill gaps in market softness, with increasing confidence in quote activity and award rates [24][25] Question: What are the segment margin targets for different business groups? - Management indicated that metals and services face headwinds from tariffs, and while they may struggle to reach the bottom of their target ranges, they expect improvement in the second half [30][31] Question: What is driving the sequential improvement in the metals segment? - Management highlighted operational improvements and regaining customer confidence as key factors driving month-to-month sequential improvement [41][43] Question: What is the status of Project Fortify Phase two? - Management confirmed minimal savings in Q1, with more significant savings expected to materialize in Q2 [48] Question: Can you quantify the EPS impact from tariffs in Q1? - Management stated that the impact was initially estimated at $0.45 to $0.55, but has been revised to $0.35 to $0.45 for the full year, with favorable trends noted in Q1 [49][50]

Financial Data and Key Metrics Changes - Net sales increased by 4.6% to $346.6 million, primarily driven by $22 million of inorganic sales from the acquisition of UW Solutions [10][11] - Adjusted EBITDA margin decreased to 9.9%, primarily due to a less favorable mix and higher aluminum costs [11] - Adjusted diluted EPS declined to $0.56, driven by lower adjusted EBITDA, higher interest expense, and a higher adjusted effective tax rate [11][12] Business Line Data and Key Metrics Changes - Metals segment net sales declined by 3.4%, with adjusted EBITDA margin decreasing to 7.3% due to a less favorable mix and higher aluminum costs [11][12] - Services segment achieved a 7.6% increase in net sales, marking its fifth consecutive quarter of growth, although adjusted EBITDA margin decreased to 5.7% due to higher tariff expenses [12] - Glass segment net sales declined, with adjusted EBITDA margin moderating due to reduced volume from lower end market demand [12] - Performance Surfaces segment saw net sales increase, driven by inorganic sales from UW Solutions, but adjusted EBITDA margin declined to 18.8% due to lower margins from UW Solutions [12] Market Data and Key Metrics Changes - The revenue pipeline for Glass is improving, positioning the segment for growth beginning in Q3 and Q4 [7][10] - Metals showed sequential improvement from Q4, with expectations for continued improvement in Q2 [6][11] Company Strategy and Development Direction - The company is focusing on operational improvements and cost mitigation strategies, particularly through Project Fortify Phase two, which is expected to drive annualized savings of $13 million to $15 million [6][10] - The company is actively pursuing M&A opportunities to diversify its business mix and enhance growth prospects [8][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in building momentum for the second half of the fiscal year, driven by improvements in metals, growth in glass revenues, and strong organic growth in Performance Surfaces [17] - The company raised its fiscal year outlook for net sales and adjusted diluted EPS, expecting net sales in the range of $1.4 billion to $1.44 billion and adjusted diluted EPS between $3.8 and $4.2 [14][17] Other Important Information - The company is experiencing challenges due to increased tariffs but is implementing successful mitigation plans [6][10] - The balance sheet remains strong, with a consolidated leverage ratio of 1.6 and no near-term debt maturities [13] Q&A Session Summary Question: Can you elaborate on the glass business and the revenue pipeline? - Management noted good visibility six months out and mentioned a pivot to smaller jobs to fill gaps due to market softness, with improved quote activity and award rates [22][24] Question: What is the outlook for segment margin targets? - Management indicated that metals and services face headwinds due to tariffs, and while they hope to reach the bottom of their target ranges, it may be challenging in the first half [28][30] Question: What is driving the sequential improvement in the metals segment? - Management highlighted operational improvements and regaining customer confidence as key factors driving sales and margin improvements [40][42] Question: What is the status of Project Fortify Phase two? - Minimal savings were seen in Q1, with more expected to materialize in Q2, particularly following the closure of a Canadian facility [45][47] Question: Can you quantify the EPS impact from tariffs in Q1? - The impact was initially estimated at $0.45 to $0.55, but was updated to $0.35 to $0.45 for the full year, with a favorable trend noted in Q1 [48][50] Question: How is the M&A pipeline being affected by the current environment? - Management stated that while M&A activity has slowed due to macro issues, they continue to focus on strategic targets identified over the past two years [63][65]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $1.67 billion, representing a 6% increase reported and 5.3% core growth year-over-year [9][27] - Operating margin was 25.1%, absorbing some incremental tariff costs, and EPS was $1.31, growing 7% compared to Q2 2024 [9][33] - Gross margin was 54.1%, down from the previous year due to tariffs, currency, and product mix [31] Business Line Data and Key Metrics Changes - The Agilent CrossLab Group reported revenue of $713 million, growing 9%, driven by double-digit growth in consumables and automation [28] - Life Sciences and Diagnostics Market Group revenue was $654 million, growing 3%, with high single-digit growth in pathology and NASD [29] - Applied Markets Group revenue was flat at $300 million, with growth in spectroscopy offset by declines in gas chromatography [29] Market Data and Key Metrics Changes - All regions experienced growth: Americas grew low single digits, EMEA grew mid single digits, and China led with 10% growth [12] - India delivered high teens growth, prompting the opening of a new solution center [13] - Environmental and forensics grew 6% globally, driven by strong demand for PFAS testing [15] Company Strategy and Development Direction - The company is executing its three-year Ignite transformation strategy, focusing on operational efficiency and tariff mitigation [11][20] - Agilent acquired BioVectra for approximately $1 billion to expand CDMO capabilities [20] - The company is committed to innovation, launching new products in cell analysis and chromatography [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term growth prospects despite macroeconomic uncertainties [26] - The company is maintaining its core growth rate guidance of 2.5% to 3.5% for the year [26][35] - Management highlighted the importance of strategic pricing initiatives to mitigate tariff impacts [21][88] Other Important Information - The company is tracking over 350 regulations globally related to PFAS testing, anticipating significant market growth by 2030 [16] - Operating cash flow was $221 million, with capital expenditures of $114 million [33] - The company ended the quarter with a net leverage ratio of 1, indicating a strong balance sheet [33] Q&A Session Summary Question: Order trends in the quarter - Management noted that orders grew low single digits in Q2, with stable business across regions and no significant pull forward from pharma tariffs [50][51] Question: Expectations for NASD and BioVectra - Management expressed confidence in double-digit growth for NASD in the second half of the year, supported by strong order visibility [56] Question: Impact of tariffs on consumables - The $15 million pull forward in consumables was driven by customer actions in response to high tariff rates, with no overall revenue impact expected [64][65] Question: Differences in ordering patterns in pharma - The majority of business is on the QAQC and development side, with small molecule growth of 10% in the quarter [72] Question: PFAS regulation impacts - PFAS testing grew 75% year-over-year, with expectations for continued strong results despite regulatory uncertainties [74] Question: Reshoring and capacity build-outs - Discussions with pharma customers regarding reshoring are still in early stages, with potential tailwinds expected in the next 2-3 years [84] Question: Pricing strategies - The company has established enterprise pricing capabilities and is on track for approximately 100 basis points of price realization for the year [88][90]

Core Viewpoint - JPMorgan has upgraded the rating of emerging market corporate bonds to "neutral allocation" due to tariff relief factors [1] Group 1 - The upgrade reflects a positive outlook for emerging market corporate bonds influenced by recent developments in trade policies [1]

摩根大通因关税缓解因素将新兴市场公司债券评级上调至 "中性配置"。 ...